Monthly ibandronate did not improve patient persistence vs weekly risedronate: 1 year data
Publication
, Conference
Gold, DT; Safi, W; Trinh, H
Published in: Osteoporosis International
April 1, 2007
Duke Scholars
Published In
Osteoporosis International
ISSN
0937-941X
Publication Date
April 1, 2007
Volume
18
Start / End Page
S223 / S224
Location
Washington, DC
Publisher
SPRINGER LONDON LTD
Conference Name
7th International Symposium on Osteoporosis
Related Subject Headings
- Endocrinology & Metabolism
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 0903 Biomedical Engineering
Citation
APA
Chicago
ICMJE
MLA
NLM
Gold, D. T., Safi, W., & Trinh, H. (2007). Monthly ibandronate did not improve patient persistence vs weekly risedronate: 1 year data. In Osteoporosis International (Vol. 18, pp. S223–S224). Washington, DC: SPRINGER LONDON LTD.
Gold, Deborah T., Wael Safi, and Haian Trinh. “Monthly ibandronate did not improve patient persistence vs weekly risedronate: 1 year data.” In Osteoporosis International, 18:S223–24. SPRINGER LONDON LTD, 2007.
Gold DT, Safi W, Trinh H. Monthly ibandronate did not improve patient persistence vs weekly risedronate: 1 year data. In: Osteoporosis International. SPRINGER LONDON LTD; 2007. p. S223–4.
Gold, Deborah T., et al. “Monthly ibandronate did not improve patient persistence vs weekly risedronate: 1 year data.” Osteoporosis International, vol. 18, SPRINGER LONDON LTD, 2007, pp. S223–24.
Gold DT, Safi W, Trinh H. Monthly ibandronate did not improve patient persistence vs weekly risedronate: 1 year data. Osteoporosis International. SPRINGER LONDON LTD; 2007. p. S223–S224.
Published In
Osteoporosis International
ISSN
0937-941X
Publication Date
April 1, 2007
Volume
18
Start / End Page
S223 / S224
Location
Washington, DC
Publisher
SPRINGER LONDON LTD
Conference Name
7th International Symposium on Osteoporosis
Related Subject Headings
- Endocrinology & Metabolism
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
- 0903 Biomedical Engineering